TNF-α-308 and INF-γ+874 gene polymorphisms in relation to susceptibility and severity of type 2 diabetes mellitus among egyptian cases

European Journal of General Medicine

Volumn 9, Issue 3, 2012, Pages 173-177

  Elsaid, Afaf ^a   Helaly, Mohamed A ^b   Hatata, El Sayed Z ^b   Fouda, Osama ^b   Settin, Ahmad ^a  

^a MANSOURA UNIVERSITY   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Egypt; Gene polymorphism; TNF 308; Type 2 DM

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE SEVERITY; DNA POLYMORPHISM; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; INF GAMMA GENE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TNF ALPHA GENE;

EID: 84872299167     PISSN: 13043889     EISSN: None     Source Type: Journal    
DOI: 10.29333/ejgm/82455     Document Type: Article

References (26)

1. Arababadi MK, Pourfathollah AA, Daneshmandi S, et al. Evaluation of Relation between IL-4 and IFN-γ Polymorphisms and Type 2 Diabetes. Iranian J Basic Med Sci 2009;12(2):100-4.
2. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 2004;27:813-23.
3. Daneshmandi S, Pourfathollah A, Arababadi MK, Hassanshahi G, Rezaeian M, Asiabanha M. Evaluation of relation between IL-4 and IFN- γ polymorphisms and type 2 diabetes. J Mazand Univ Med Sci 2008;18:35-41.
4. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 1995;92:2409-15.
5. Wastowski IJ, Peres NT, Simoes RT, et al. Identification of a novel 120 bp allele at the TNFα microsatellite locus. Tissue Antigens 2006;67(4):318-20
6. Hajeer AH, Hutchinson IV. Influence of TNF alpha gene polymorphisms on TNF alpha production and disease. Hum Immunol 2001;62(11):1191-9.
7. Stalenhoef JE, Alisjahbana B, Nelwan EJ, et al. The role of interferon-gamma in the increased tuberculosis risk in type 2 diabetes mellitus. Eur J Clin Microbiol Infect Dis 2008;27:97-103
8. Cantor MJ, Nickerson P, Bernstein CN. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease. Am J Gastroenterol 2005;100:1134-42.
9. Trinder P. Determination of blood glucose using an oxidase peroxidase system with an alternative oxygen acceptor. Ann Clin Biochem 1969;6:24-7.
10. Frier BM, Ashby JP, Nairn IM, Blairs JD. Plasma insulin, C-peptide and glucagons concentration in patients with insulin dependent diabetes treated with chlorpropamide. Diab Metab 1981;7(1):45-9.
11. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis Model of Assessment of insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia 1985;28:412-9.
12. Aldener-Cannava A, Olerup O. HLA-DOB1 "Low-resolution" tying by PCR amplification with sequence-specific primers (PCR-SSP). Eur Immunogenet 1994;21:447-55.
13. Perrey C, Turner SJ, Pravica V, Howell WM, Hutchinson IV. ARMS-PCR methodologies to determine IL-10, TNF-alpha, TNF-beta and TGF-beta1 gene polymorphism. Transpl Immunol 1999;7:127-8.
14. Pravica V, Perrey C, Sievens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene; absolute correlation with polymorphic CA microsateline marker of high IFN-gamma gene. Hum Immunol 2000;61:863-6.
15. Steven E. Stern, Ken Williams, Eleuterio Ferrannini, Ralph A. DeFronzo, Clifton Bogardus, and Michael P. Stern. Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements. Diabetes 2005;54:333-9.
16. American Diabetes Association. Standards of Medical Care in Diabetes-2011. Diabetes Care 2011;34(suppl.1):S11-61.
17. Sullivan PW, Morrato EH, Ghushchyan V, Wyatt HR, Hill JO. Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the US, 2000-2002. Diabetes Care 2005;28(7):1599-603.
18. Shiba T, Higashi N, Nishimura Y. Hyperglycemia due to insulin resistance caused by interferon-gamma. Diabet Med 1998;15:435-6.
19. Kubaszek A, Pihlajamäki J, Komarovski V, et al. Finnish Diabetes Prevention Study. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes 2003;52(7):1872-6.
20. Wilson AG, Sympons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94(7):3195-9.
21. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, Arner P. Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 2000;43:117-20.
22. Herrmann SM, Ricard S, Nicaud V, et al. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 1998;28:59-66.
23. Lee SC, Pu YB, Thomas GN, et al. Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 2000;49(8):1021-4.
24. Settin A, Ismail A, Abo El-Magd M, El-Baz R, Kazamel A. Gene polymorphisms of TNF-a 308 (G/A), IL-1021082 (G/A), IL-62174 (G/C) and IL-1Ra (VNTR) in Egyptian cases with type 1 diabetes mellitus. Autoimmunity 2009;42(1):50-5
25. Furuta M, Yano Y, Ito K, et al. Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2002;56(2):141-5.
26. Tsiavou A, Hatziagelaki E, Chaidaroglou A, Koniavitou K, Degiannis D, Raptis SA. Correlation between intracellular interferon-gamma (IFN-gamma) production by CD4+ and CD8+ lymphocytes and IFN-gamma gene polymorphism in patients with type 2 diabetes mellitus and latent autoimmune diabetes of adults (LADA). Cytokine 2005;31(2):135-41.